Lixte Cash vs Net Debt Analysis

LIXT Stock  USD 1.99  0.08  4.19%   
Lixte Biotechnology financial indicator trend analysis is infinitely more than just investigating Lixte Biotechnology recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Lixte Biotechnology is a good investment. Please check the relationship between Lixte Biotechnology Cash and its Net Debt accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lixte Biotechnology Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

Cash vs Net Debt

Cash vs Net Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Lixte Biotechnology Cash account and Net Debt. At this time, the significance of the direction appears to have pay attention.
The correlation between Lixte Biotechnology's Cash and Net Debt is -1.0. Overlapping area represents the amount of variation of Cash that can explain the historical movement of Net Debt in the same time period over historical financial statements of Lixte Biotechnology Holdings, assuming nothing else is changed. The correlation between historical values of Lixte Biotechnology's Cash and Net Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash of Lixte Biotechnology Holdings are associated (or correlated) with its Net Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Debt has no effect on the direction of Cash i.e., Lixte Biotechnology's Cash and Net Debt go up and down completely randomly.

Correlation Coefficient

-1.0
Relationship DirectionNegative 
Relationship StrengthStrong

Cash

Cash refers to the most liquid asset of Lixte Biotechnology, which is listed under current asset account on Lixte Biotechnology Holdings balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Lixte Biotechnology customers. The amounts must be unrestricted with restricted cash listed in a different Lixte Biotechnology account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.
Most indicators from Lixte Biotechnology's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Lixte Biotechnology current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lixte Biotechnology Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
At this time, Lixte Biotechnology's Selling General Administrative is comparatively stable compared to the past year. Issuance Of Capital Stock is likely to gain to about 3.9 M in 2024, whereas Sales General And Administrative To Revenue is likely to drop 3.02 in 2024.

Lixte Biotechnology fundamental ratios Correlations

0.650.240.96-0.97-0.760.950.96-0.280.760.241.0-0.3-0.320.460.81-0.340.73-0.110.91-0.660.40.350.580.720.95
0.650.460.63-0.63-0.720.630.640.030.70.460.65-0.19-0.30.410.68-0.50.54-0.230.75-0.470.420.720.370.550.66
0.240.460.21-0.22-0.450.220.230.180.431.00.240.13-0.790.660.33-0.210.26-0.120.25-0.010.710.480.040.20.16
0.960.630.21-1.0-0.841.01.0-0.310.860.210.96-0.4-0.30.420.8-0.380.83-0.350.88-0.710.320.340.640.730.98
-0.97-0.63-0.22-1.00.83-1.0-1.00.31-0.85-0.22-0.970.380.3-0.43-0.790.42-0.810.32-0.890.72-0.33-0.34-0.63-0.75-0.97
-0.76-0.72-0.45-0.840.83-0.84-0.840.35-0.99-0.45-0.750.380.48-0.51-0.730.28-0.860.59-0.720.71-0.55-0.69-0.41-0.79-0.81
0.950.630.221.0-1.0-0.841.0-0.310.860.220.95-0.39-0.30.430.78-0.430.82-0.360.88-0.720.320.330.630.750.97
0.960.640.231.0-1.0-0.841.0-0.280.860.230.96-0.4-0.310.440.79-0.420.83-0.360.88-0.710.330.330.650.740.98
-0.280.030.18-0.310.310.35-0.31-0.28-0.330.18-0.28-0.010.010.04-0.18-0.2-0.20.1-0.10.37-0.03-0.310.04-0.35-0.25
0.760.70.430.86-0.85-0.990.860.86-0.330.430.76-0.44-0.460.460.74-0.310.89-0.640.74-0.680.510.650.490.750.83
0.240.461.00.21-0.22-0.450.220.230.180.430.240.13-0.790.660.33-0.210.26-0.120.25-0.010.710.480.040.20.16
1.00.650.240.96-0.97-0.750.950.96-0.280.760.24-0.29-0.320.460.81-0.340.73-0.10.91-0.660.390.340.580.720.95
-0.3-0.190.13-0.40.380.38-0.39-0.4-0.01-0.440.13-0.29-0.350.16-0.610.32-0.770.51-0.450.180.19-0.21-0.66-0.11-0.45
-0.32-0.3-0.79-0.30.30.48-0.3-0.310.01-0.46-0.79-0.32-0.35-0.55-0.17-0.1-0.20.12-0.220.11-0.87-0.290.03-0.33-0.24
0.460.410.660.42-0.43-0.510.430.440.040.460.660.460.16-0.550.4-0.130.310.00.29-0.540.440.29-0.130.610.41
0.810.680.330.8-0.79-0.730.780.79-0.180.740.330.81-0.61-0.170.4-0.370.85-0.160.83-0.50.240.510.580.530.83
-0.34-0.5-0.21-0.380.420.28-0.43-0.42-0.2-0.31-0.21-0.340.32-0.1-0.13-0.37-0.340.27-0.490.270.03-0.09-0.44-0.24-0.35
0.730.540.260.83-0.81-0.860.820.83-0.20.890.260.73-0.77-0.20.310.85-0.34-0.60.77-0.560.290.480.670.580.84
-0.11-0.23-0.12-0.350.320.59-0.36-0.360.1-0.64-0.12-0.10.510.120.0-0.160.27-0.6-0.180.3-0.14-0.3-0.38-0.28-0.3
0.910.750.250.88-0.89-0.720.880.88-0.10.740.250.91-0.45-0.220.290.83-0.490.77-0.18-0.530.330.470.660.580.9
-0.66-0.47-0.01-0.710.720.71-0.72-0.710.37-0.68-0.01-0.660.180.11-0.54-0.50.27-0.560.3-0.53-0.16-0.3-0.05-0.96-0.7
0.40.420.710.32-0.33-0.550.320.33-0.030.510.710.390.19-0.870.440.240.030.29-0.140.33-0.160.460.050.430.28
0.350.720.480.34-0.34-0.690.330.33-0.310.650.480.34-0.21-0.290.290.51-0.090.48-0.30.47-0.30.460.060.410.35
0.580.370.040.64-0.63-0.410.630.650.040.490.040.58-0.660.03-0.130.58-0.440.67-0.380.66-0.050.050.060.060.66
0.720.550.20.73-0.75-0.790.750.74-0.350.750.20.72-0.11-0.330.610.53-0.240.58-0.280.58-0.960.430.410.060.71
0.950.660.160.98-0.97-0.810.970.98-0.250.830.160.95-0.45-0.240.410.83-0.350.84-0.30.9-0.70.280.350.660.71
Click cells to compare fundamentals

Lixte Biotechnology Account Relationship Matchups

Lixte Biotechnology fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets2.7M5.2M5.1M5.6M4.3M2.2M
Other Current Liab237.9K10.5K302.9K394.8K313.9K171.6K
Total Current Liabilities237.9K216.5K302.9K394.8K313.9K290.7K
Total Stockholder Equity2.4M5.0M4.8M5.2M4.0M4.2M
Net Debt(2.6M)(5.1M)(4.8M)(5.4M)(4.2M)(4.0M)
Retained Earnings(27.1M)(30.4M)(37.1M)(43.4M)(48.5M)(46.1M)
Cash2.6M5.1M4.8M5.4M4.2M4.4M
Cash And Short Term Investments2.6M5.1M4.8M5.4M4.2M4.4M
Common Stock Shares Outstanding1.1M1.1M1.3M158.2K1.9M1.8M
Liabilities And Stockholders Equity2.7M5.2M5.1M5.6M4.3M2.2M
Other Stockholder Equity26.0M31.9M38.4M45.1M49.0M51.4M
Total Liab237.9K216.5K302.9K394.8K313.9K290.7K
Total Current Assets2.7M5.2M5.1M5.6M4.2M2.2M
Accounts Payable143.5K190.3K226.0K229.8K156.8K169.4K
Other Current Assets58.8K159.2K10.2K10.4K27.1K25.8K
Short Term Debt210.9K237.9K302.9K394.8K313.9K193.4K
Current Deferred Revenue94.3K15.8K77.0K165.0K157.1K81.5K
Net Tangible Assets625.8K(1.1M)1.5M1.3M1.5M1.6M
Net Invested Capital(1.1M)1.5M1.3M1.7M494.8K317K
Net Working Capital2.4M5.0M4.8M5.2M4.0M4.2M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Lixte Stock Analysis

When running Lixte Biotechnology's price analysis, check to measure Lixte Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lixte Biotechnology is operating at the current time. Most of Lixte Biotechnology's value examination focuses on studying past and present price action to predict the probability of Lixte Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lixte Biotechnology's price. Additionally, you may evaluate how the addition of Lixte Biotechnology to your portfolios can decrease your overall portfolio volatility.